Securian Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$891K Hold
3,967
0.04% 371
2025
Q4
$956K Sell
3,967
-3,101
-44% -$793K 0.04% 339
2025
Q3
$1.93M Sell
7,068
-612
-8% -$167K 0.05% 266
2025
Q2
$1.98M Sell
7,680
-139
-2% -$33.2K 0.06% 259
2025
Q1
$1.75M Hold
7,819
0.05% 280
2024
Q4
$1.79M Sell
7,819
-200
-2% -$48.2K 0.05% 275
2024
Q3
$1.96M Sell
8,019
-400
-5% -$89.4K 0.06% 271
2024
Q2
$1.61M Sell
8,419
-204
-2% -$41.4K 0.05% 305
2024
Q1
$1.71M Sell
8,623
-690
-7% -$126K 0.05% 301
2023
Q4
$1.6M Sell
9,313
-1,221
-12% -$188K 0.05% 312
2023
Q3
$1.56M Sell
10,534
-1,644
-13% -$297K 0.05% 322
2023
Q2
$2.66M Sell
12,178
-100
-0.8% -$22.3K 0.07% 255
2023
Q1
$2.69M Buy
12,278
+100
+0.8% +$21.7K 0.07% 251
2022
Q4
$2.53M Sell
12,178
-126
-1% -$27.7K 0.07% 256
2022
Q3
$2.69M Buy
12,304
+200
+2% +$45.5K 0.08% 228
2022
Q2
$2.54M Sell
12,104
-100
-0.8% -$21.3K 0.06% 289
2022
Q1
$2.96M Sell
12,204
-100
-0.8% -$24.2K 0.06% 304
2021
Q4
$3.21M Sell
12,304
-159
-1% -$41.3K 0.06% 297
2021
Q3
$3.29M Sell
12,463
-200
-2% -$54.7K 0.07% 274
2021
Q2
$3.12M Sell
12,663
-100
-0.8% -$21K 0.06% 286
2021
Q1
$2.48M Sell
12,763
-335
-3% -$67.2K 0.05% 330
2020
Q4
$2.78M Sell
13,098
-418
-3% -$83.3K 0.06% 292
2020
Q3
$2.32M Hold
13,516
0.06% 315
2020
Q2
$2.6M Sell
13,516
-877
-6% -$143K 0.07% 263
2020
Q1
$2.12M Sell
14,393
-193
-1% -$30.7K 0.06% 281
2019
Q4
$2.26M Sell
14,586
-331
-2% -$47.7K 0.05% 345
2019
Q3
$2.02M Sell
14,917
-200
-1% -$26.2K 0.05% 358
2019
Q2
$1.84M Buy
15,117
+179
+1% +$19.8K 0.04% 384
2019
Q1
$1.55M Buy
14,938
+269
+2% +$27.8K 0.04% 411
2018
Q4
$1.67M Hold
14,669
0.04% 352
2018
Q3
$1.69M Hold
14,669
0.04% 395
2018
Q2
$1.52M Buy
14,669
+136
+0.9% +$13.8K 0.04% 415
2018
Q1
$1.43M Hold
14,533
0.04% 433
2017
Q4
$1.23M Buy
14,533
+166
+1% +$13.7K 0.03% 503
2017
Q3
$1.11M Sell
14,367
-3,537
-20% -$271K 0.03% 497
2017
Q2
$1.39M Sell
17,904
-233
-1% -$16.7K 0.04% 413
2017
Q1
$1.3M Buy
18,137
+617
+4% +$42.6K 0.03% 417
2016
Q4
$1.09M Buy
17,520
+395
+2% +$24.2K 0.03% 470
2016
Q3
$1.11M Buy
17,125
+120
+0.7% +$7.99K 0.03% 464
2016
Q2
$1.07M Sell
17,005
-1,873
-10% -$110K 0.03% 452
2016
Q1
$1.09M Buy
18,878
+571
+3% +$32.3K 0.03% 447
2015
Q4
$983K Sell
18,307
-1,251
-6% -$70.5K 0.03% 476
2015
Q3
$997K Sell
19,558
-346
-2% -$18.6K 0.03% 458
2015
Q2
$1.12M Sell
19,904
-128
-0.6% -$8.08K 0.04% 446
2015
Q1
$1.44M Buy
20,032
+537
+3% +$34.9K 0.04% 376
2014
Q4
$1.09M Sell
19,495
-300
-2% -$15.7K 0.03% 434
2014
Q3
$975K Buy
19,795
+133
+0.7% +$6.77K 0.03% 460
2014
Q2
$995K Sell
19,662
-769
-4% -$38.1K 0.03% 451
2014
Q1
$913K Sell
20,431
-100
-0.5% -$4.49K 0.03% 470
2013
Q4
$967K Sell
20,531
-620
-3% -$31.4K 0.04% 453
2013
Q3
$1.12M Sell
21,151
-196
-0.9% -$9.51K 0.04% 392
2013
Q2
$963K Buy
+21,347
New +$1.01M 0.04% 404

Other funds holding RMD

Securian Asset Management's RMD Position: Q1 2026 in Review

Securian Asset Management held its ResMed (RMD) position steady in Q1 2026 at 3,967 shares worth $891K. The position accounts for 0.04% of the portfolio, ranked #371.

Securian Asset Management first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.29M in Q3 2021. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Securian Asset Management held 3,967 shares of ResMed worth $891K as of Q1 2026.
  • Securian Asset Management left its ResMed share count unchanged in Q1 2026.
  • ResMed made up 0.04% of Securian Asset Management's portfolio in Q1 2026, its #371 holding.
  • Securian Asset Management first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • Securian Asset Management's ResMed position peaked at $3.29M in Q3 2021.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Securian Asset Management's 13F filing for Q1 2026, filed 1 May 2026.